Liu Ming, Pan Hong, Zhang Feng, Zhang Yong-Biao, Zhang Yang, Xia Han, Zhu Jing, Fu Wei-Ling, Zhang Xiao-Li
Cardiothoracic Surgery Department, Affiliated Daping Hospital, Third Military Medical University, Chongqing, China E-mail :
Asian Pac J Cancer Prev. 2013;14(11):6281-6. doi: 10.7314/apjcp.2013.14.11.6281.
To further investigate the molecular basis of lung cancer development, we utilize a microarray to identify differentially expressed genes associated with various TNM stages of adenocarcinoma, a subtype with increasing incidence in recent years in China.
A 35K oligo gene array, covering about 25,100 genes, was used to screen differentially expressed genes among 90 tumor samples of lung adenocarcinoma in various TNM stages. To verify the gene array data, three genes (Zimp7, GINS2 and NAG-1) were confirmed by real-time RT-PCR in a different set of samples from the gene array.
First, we obtained 640 differentially expressed genes in lung adenocarcinomas compared to the surrounding normal lung tissues. Then, from the 640 candidates we identified 10 differentially expressed genes among different TNM stages (Stage I, II and IIIA), of which Zimp7, GINS2 and NAG-1 genes were first reported to be present at a high level in lung adenocarcinoma. The results of qRT-PCR for the three genes were consistent with those from the gene array.
We identified 10 candidate genes associated with different TNM stages in lung adenocarcinoma in the Chinese population, which should provide new insights into the molecular basis underlying the development of lung adenocarcinoma and may offer new targets for the diagnosis, therapy and prognosis prediction.
为进一步探究肺癌发生发展的分子基础,我们利用微阵列技术来鉴定与腺癌不同TNM分期相关的差异表达基因,腺癌是近年来在中国发病率不断上升的一种亚型。
使用一个覆盖约25100个基因的35K寡核苷酸基因阵列,对90例处于不同TNM分期的肺腺癌肿瘤样本中的差异表达基因进行筛选。为验证基因阵列数据,在一组来自基因阵列的不同样本中,通过实时逆转录聚合酶链反应对三个基因(Zimp7、GINS2和NAG-1)进行了确认。
首先,与周围正常肺组织相比,我们在肺腺癌中获得了640个差异表达基因。然后,从这640个候选基因中,我们在不同TNM分期(I期、II期和IIIA期)中鉴定出10个差异表达基因,其中Zimp7、GINS2和NAG-1基因首次被报道在肺腺癌中高水平存在。这三个基因的定量逆转录聚合酶链反应结果与基因阵列结果一致。
我们在中国人群中鉴定出10个与肺腺癌不同TNM分期相关的候选基因,这应为肺腺癌发生发展的分子基础提供新的见解,并可能为诊断、治疗及预后预测提供新的靶点。